$CLX

Clorox’s 5.8% Dividend Yield: Bargain or Warning Sign?

Clorox (NYSE:CLX) reported a 5% decline in net sales to $6.72B and a 26% drop in EPS to $4.81 for FY2026, with gross margin falling 290bps to 42.3%. Operating cash flow decreased 38% to $612M. The company projects FY2027 organic sales growth of 3.5-4.5% and EPS growth of 3-8%. CLX trades at a forward P/E of 14.95, offering a 5.8% dividend yield, but faces challenges in sustaining profitability and growth.

Original reporting
Published Oct 17, 2026, 5:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 17, 2026, 5:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Clorox’s 5.8% Dividend Yield: Bargain or Warning Sign? — source image
Decision brief

The 30-second read

$CLXBearishLow
01

Why it matters

The recapped numbers suggest margin pressure and limited cash to support the dividend, likely prompting caution among investors.

02

Market read

The article provides a dividend‑valuation perspective on CLX after its earnings release, offering limited new actionable insight.

03

What to watch

Potential brand strength and future acquisition synergies are not fully priced in.

Relevance 4/10Novelty 2/10Timing: none

Background

Clorox reported FY2026 results with lower sales, earnings, and cash flow, and discussed dividend sustainability.

Company-level read

Ticker impact

$CLXBearishMedium confidence
Context

The article recaps FY2026 earnings and guidance that were released 75 days earlier, highlighting declining profitability, cash flow, and dividend sustainability concerns.

Expected impact

likely downside pressure as investors reassess the high dividend yield amid weak cash flow

Evidence & confidence

Recapped earnings and guidance show margin compression and cash flow decline, suggesting limited capacity to maintain the 5.8% yield, which could prompt sell‑offs.

Market effects

Highlights challenges for dividend‑focused consumer staples stocks amid cost pressures.

US consumer staples may see modest valuation pressure.

Limited; primarily affects CLX and similar dividend‑yield investors.

Counterpoint

The high yield could attract income‑seeking investors if cash flow improves.

Key entities

  • The Clorox Company

    US consumer‑goods company with ticker CLX.

Related articles

$KMBMedAI 8/10

Kimberly-Clark vs. Clorox: The Higher Yield May Not Be the Better Dividend

Kimberly-Clark (KMB) and Clorox (CLX) reported earnings, highlighting their respective overhauls. KMB beat EPS estimates with $2.12, but faces China-related challenges. CLX saw gross margin decline due to higher costs. Both have high dividend payout ratios, with CLX offering a higher yield but carrying more debt. KMB's stock is up 10.28% YTD, while CLX is down 11.85%.

$KMBMed

Kimberly-Clark vs. Clorox: Which Dividend Stock Pays You More in 10 Years?

Clorox (CLX) and Kimberly-Clark (KMB) are compared for their dividend payouts. CLX offers a 6.2% yield, but its dividends exceeded free cash flow in fiscal 2026. KMB yields 5.4%, with dividends covered by free cash flow. CLX's net debt increased post-acquisition, while KMB faces China-related sales challenges. Both companies' dividend policies and financial health are analyzed.

$KHCMed

Better High-Yield Dividend Stock: Kraft Heinz vs. Clorox

Kraft Heinz (KHC) and Clorox (CLX) are compared as high-yield dividend stocks. KHC yields 7.2% with a 50% payout ratio, while CLX yields 6.1% with a 149% payout ratio. KHC guided 2026 adjusted operating income down 16-18%, and CLX's free cash flow fell to $405M in fiscal 2026. CLX's debt increased to 4.3x EBITDA post-GOJO deal.

$CLXMed

Can Cost Savings Offset Inflation & Protect Clorox's Margins?

Clorox (CLX) reported a 520 basis point gross margin contraction in Q4 fiscal 2026 due to inflation and mix challenges. The company is focusing on cost savings and productivity initiatives to offset inflationary pressures, but expects margins to remain pressured in fiscal 2027. CLX shares have risen 5.2% in the past three months, with a forward P/E of 15.97X.